Why would a pharmaceutical company not encourage people to buy its drug? Could it be because it also sells an alternative at 40 times the price?rnThe two products are treatments for the "wet" form of age-related macular degeneration (AMD), which can rapidly lead to blindness (see main story). The expensive version - Lucentis - is about $2000 per injection, and patients may need a shot every 4 to 6 weeks.
展开▼
